Illumina, Inc. (NASDAQ:ILMN) announced that it has filed two patent infringement suits in Europe.
Illumina, Inc. (NASDAQ:ILMN) announced that its Board of Directors has authorized the company to repurchase, on a discretionary basis, up to $250 million of …
Illumina, Inc. (NASDAQ:ILMN) announced its financial results for the third quarter of fiscal year 2015.
In a research report released Wednesday, William Blair analyst Amanda Murphy reiterated an Outperform rating on shares of Illumina, Inc. (NASDAQ:ILMN), following the company’s preliminary …
Illumina, Inc. (NASDAQ:ILMN) announced the launch of new TruSeq® library preparation kits and Infinium® arrays that enable researchers to explore genetic variation on a …
Analysts are weighing in on the gene-sequencing company Illumina, Inc. (NASDAQ:ILMN) and molecular diagnostics company EXACT Sciences Corporation (NASDAQ:EXAS), as shares of both companies are trading …
Illumina, Inc. (NASDAQ:ILMN) announced estimated third quarter revenue of approximately $550 million, a 14% increase compared to $481 million in the third quarter of 2014 and …
Illumina, Inc. (NASDAQ:ILMN) announced several new additions to BaseSpace—the world’s largest and most comprehensive cloud computing environment—with the launch of BaseSpace Professional and Enterprise …
Illumina, Inc. (NASDAQ:ILMN) announced it has launched TruSight® Tumor 15, a next-generation sequencing (NGS) panel designed to identify sequence variants in 15 genes commonly …
Memorial Sloan Kettering Cancer Center (MSK) and Illumina, Inc. (NASDAQ:ILMN) announced a collaboration to conduct research studies that are critical to understanding the …
